(firstQuint)Evaluation of APAP With SensAwake in OSA and Insomnia Patients.

 Patients with OSA and Insomnia will be enrolled into this randomized study to receive treatment with APAP with and without SensAwake.

 Baseline data will be collected for one week prior to CPAP initiation, followed by two treatment periods on each study arm of four weeks each.

.

 Evaluation of APAP With SensAwake in OSA and Insomnia Patients@highlight

The hypothesis is that APAP with SensAwake improves wake-after sleep onset compared to APAP without SensAwake in a patient population with Obstructive Sleep Apnea Syndrome (OSAS) and Insomnia.

